Protara Therapeutics, Inc. (TARA)
3.905
+0.04
(+1.17%)
USD |
NASDAQ |
Sep 01, 16:00
3.905
0.00 (0.00%)
After-Hours: 20:00
Protara Therapeutics Cash and Short Term Investments (Quarterly) : 142.49M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 142.49M |
| March 31, 2026 | 135.79M |
| December 31, 2025 | 155.55M |
| September 30, 2025 | 132.67M |
| June 30, 2025 | 122.22M |
| March 31, 2025 | 124.36M |
| December 31, 2024 | 170.29M |
| September 30, 2024 | 81.50M |
| June 30, 2024 | 89.58M |
| March 31, 2024 | 55.22M |
| December 31, 2023 | 65.58M |
| September 30, 2023 | 74.03M |
| June 30, 2023 | 80.36M |
| March 31, 2023 | 86.61M |
| December 31, 2022 | 84.37M |
| September 30, 2022 | 96.32M |
| June 30, 2022 | 98.46M |
| March 31, 2022 | 87.59M |
| December 31, 2021 | 91.23M |
| September 30, 2021 | 93.76M |
| June 30, 2021 | 84.67M |
| March 31, 2021 | 84.40M |
| December 31, 2020 | 168.65M |
| September 30, 2020 | 165.95M |
| June 30, 2020 | 30.02M |
| Date | Value |
|---|---|
| March 31, 2020 | 36.12M |
| December 31, 2019 | 0.564M |
| September 30, 2019 | 9.371M |
| June 30, 2019 | 10.81M |
| March 31, 2019 | 16.76M |
| December 31, 2018 | 21.87M |
| September 30, 2018 | 26.21M |
| June 30, 2018 | 26.45M |
| March 31, 2018 | 36.82M |
| December 31, 2017 | 42.14M |
| September 30, 2017 | 47.43M |
| June 30, 2017 | 31.74M |
| March 31, 2017 | 34.13M |
| December 31, 2016 | 41.32M |
| September 30, 2016 | 46.97M |
| June 30, 2016 | 53.67M |
| March 31, 2016 | 59.39M |
| December 31, 2015 | 65.26M |
| September 30, 2015 | 70.55M |
| June 30, 2015 | 74.74M |
| March 31, 2015 | 79.52M |
| December 31, 2014 | 83.60M |
| September 30, 2014 | 21.72M |
| June 30, 2014 | 25.46M |
| March 31, 2014 | 3.625M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| NovelStem International Corp. | 0.0562M |
| Brainstorm Cell Therapeutics, Inc. | 0.022M |
| Summit Therapeutics, Inc. | 691.00M |
| Kezar Life Sciences, Inc. | 66.23M |
| Clene, Inc. | 9.671M |